ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 272,32
-0,03%
Dow Jones
42 788,35
-0,12%
DAX
19 848,77
-0,34%
Brent Oil
72,56
-0,21%
Bitcoin
92 471,68
-2,77%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Indivior PLC (INDV) Cours

Indivior PLC

Indivior PLC (INDV)

Indivior Plc
11,8482
0,1882
( 1,61% )
Mis à jour : 20:51:31
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
11,8482
Prix Achat
11,83
Prix Vente
11,86
Volume échangé
165 922
11,75 Fourchette du Jour 11,90
7,33 Plage de 52 semaines 23,22
Cap du marché
1,535B
Clôture Veille
11,66
Ouverture
11,80
Dernière Transaction
43
@
11.84
Dernière heure de transaction
20:54:10
Volume financier
US$ 1 962 350
VWAP
11,8269
Volume moyen (3 m)
1 305 464
Actions en circulation
129 575 205
Rendement du Dividende
-
Ratio Cours sur Bénéfices
613,64
Bénéfice par action (BPA)
0,02
Chiffre d'affairess
1,09B
Bénéfice net
2M

À propos de Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by... Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.indivior.com
Siège social
Berkshire, Gbr
Fondé
-
Indivior PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker INDV. Le dernier cours de clôture d'Indivior était de US$11,66. Au cours de la dernière année, les actions de Indivior ont été négociées dans une fourchette de prix de US$ 7,33 à US$ 23,22.

Indivior compte actuellement 129 575 205 actions en circulation. La capitalisation boursière d'Indivior est de US$1,51 milliard. Indivior a un ratio cours/bénéfice (ratio PE) de 613.64.

INDV Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

il y a 2 heures
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

18 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

03 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

02 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Novembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 Novembre 2024
Edgar (US Regulatory)

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM...

19 Novembre 2024
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.16821.4400684931511.6812.199911.2809134403511.70339125CS
40.98829.0994475138110.8612.199910.62127418811.47510604CS
121.918219.31722054389.9312.19997.3313054649.99030264CS
26-4.5218-27.622480146616.3716.697.33105282410.53004391CS
52-3.3318-21.948616600815.1823.227.3358696211.28779135CS
156-14.6518-55.289811320826.526.57.3338651011.42112515CS
260-14.6518-55.289811320826.526.57.3338651011.42112515CS

INDV - Frequently Asked Questions (FAQ)

What is the current Indivior share price?
The current share price of Indivior is US$ 11,8482
How many Indivior shares are in issue?
Indivior has 129 575 205 shares in issue
What is the market cap of Indivior?
The market capitalisation of Indivior is USD 1,51B
What is the 1 year trading range for Indivior share price?
Indivior has traded in the range of US$ 7,33 to US$ 23,22 during the past year
What is the PE ratio of Indivior?
The price to earnings ratio of Indivior is 613,64
What is the cash to sales ratio of Indivior?
The cash to sales ratio of Indivior is 1,12
What is the reporting currency for Indivior?
Indivior reports financial results in USD
What is the latest annual turnover for Indivior?
The latest annual turnover of Indivior is USD 1,09B
What is the latest annual profit for Indivior?
The latest annual profit of Indivior is USD 2M
What is the registered address of Indivior?
The registered address for Indivior is 234 BATH ROAD, SLOUGH, BERKSHIRE, SL1 4EE
What is the Indivior website address?
The website address for Indivior is www.indivior.com
Which industry sector does Indivior operate in?
Indivior operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DRCTDirect Digital Holdings Inc
US$ 3,58
(550,91%)
50,87M
CHEKCheck Cap Ltd
US$ 2,20
(272,88%)
29,52M
TRAWTraws Pharma Inc
US$ 13,05
(159,96%)
26,76M
RELIReliance Global Group Inc
US$ 2,85
(137,50%)
100,8M
RAPTRAPT Therapeutics Inc
US$ 1,7399
(110,79%)
129,2M
AILEiLearningEngines Inc
US$ 0,2394
(-72,95%)
19,66M
MGOLMGO Global Inc
US$ 0,4745
(-50,05%)
12,66M
YHCLQR House Inc
US$ 1,085
(-38,00%)
1,19M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4041
(-33,93%)
159,1M
ADGMAdagio Medical Holdings Inc
US$ 1,125
(-31,82%)
4,51M
EDBLEdible Garden AG Inc
US$ 0,3836
(61,38%)
390,07M
RGTIRigetti Computing Inc
US$ 11,1143
(18,62%)
206,26M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4041
(-33,93%)
159,1M
RIMEAlgorhythm Holdings Inc
US$ 0,0911
(19,24%)
135,15M
RAPTRAPT Therapeutics Inc
US$ 1,7399
(110,79%)
129,73M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
INDV
Indivior
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés